CRIS (Curis Inc) Stock Analysis - AI Report

Curis Inc (CRIS) is a publicly traded Healthcare sector company. As of May 21, 2026, CRIS trades at $0.50 with a market cap of $18.71M and a P/E ratio of -0.62. CRIS moved +4.22% today. Year to date, CRIS is -49.71%; over the trailing twelve months it is -76.64%. Its 52-week range spans $0.46 to $5.54. Analyst consensus is strong buy with an average price target of $11.00. Rallies surfaces CRIS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on CRIS?

Rallies AI research for CRIS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

CRIS Key Metrics

Key financial metrics for CRIS
MetricValue
Price$0.50
Market Cap$18.71M
P/E Ratio-0.62
EPS$-0.81
Dividend Yield0.00%
52-Week High$5.54
52-Week Low$0.46
Volume0
Avg Volume0
Revenue (TTM)$7.06M
Net Income$-21.16M
Gross Margin0.00%

Latest CRIS News

Recent CRIS Insider Trades

  • KAITIN KENNETH I bought 10.00K (~$5.49K) on Mar 31, 2026.

CRIS Analyst Consensus

3 analysts cover CRIS: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $11.00.

Common questions about CRIS

What is the AI research view on CRIS?
Rallies AI research for CRIS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for CRIS?
Rallies AI research for CRIS combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is CRIS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CRIS. It does not provide personalized investment advice.
CRIS

CRIS